Wang Sheng-Meng, Wang Ting-Cheng, Giang Yun-Seng
Department of Forensic Science, Central Police University, Kueishan, Taoyuan 33334, Taiwan, ROC.
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):131-43. doi: 10.1016/j.jchromb.2004.11.027.
A simple, rapid, reliable, and economic analytical scheme starting with in situ liquid-liquid extraction and asymmetric (or diastereomeric) chemical derivatization (ChD) followed by gas chromatography (GC)-isotope dilution mass spectrometry (MS) is described for the simultaneous determination of D- and L-amphetamine (AP) and methamphetamine (MA) in urine which could have resulted from the administration of various forms of questioned amphetamines or amphetamines-generating drugs. By using L-N-trifluoroacetyl-1-prolyl chloride (L-TPC) as chiral derivatizing agent, resolutions of 2.2 and 2.0 were achieved for the separation of AP and MA enantiomeric pairs, respectively, on an ordinary HP-5MS capillary column. The GC-MS quantitation was carried out in the selected ion monitoring (SIM) mode using m/z 237 and 251 as the quantifier ions for the respective diastereomeric pairs of AP-L-TPC and MA-L-TPC. The calibration curves plotted for the two pairs of analytes stretch with good linearity down to 45 ng/mL, and the limits of detection and quantitation determined were as low as 40 and 45 ng/mL, respectively. Also, a comparative study using 10 real-case urine specimens previously screened as positive for MA administration showed mostly tolerable biases between the two sums (of concentration) of D- and L-MA obtained via an asymmetric L-TPC-ChD approach and via an ordinary pentafluoropropionylation (PFPA-ChD) approach, respectively, as well as between the two sums of D- and L-AP obtained thereupon, thus validating the proposed analytical scheme as a promising forensic protocol for the detailed analysis of enantiomeric amphetamines in urine.
本文描述了一种简单、快速、可靠且经济的分析方法,该方法首先进行原位液-液萃取和不对称(或非对映体)化学衍生化(ChD),然后采用气相色谱(GC)-同位素稀释质谱(MS),用于同时测定尿液中的D-和L-苯丙胺(AP)以及甲基苯丙胺(MA),这些物质可能来自于各种形式的可疑苯丙胺类药物或能产生苯丙胺的药物。通过使用L-N-三氟乙酰基-1-脯氨酰氯(L-TPC)作为手性衍生化试剂,在普通的HP-5MS毛细管柱上分别实现了AP和MA对映体对的分离度为2.2和2.0。GC-MS定量分析采用选择离子监测(SIM)模式,使用m/z 237和251作为AP-L-TPC和MA-L-TPC各自非对映体对的定量离子。两对分析物绘制的校准曲线在低至45 ng/mL时具有良好的线性,测定的检测限和定量限分别低至40和45 ng/mL。此外,一项比较研究使用了10份先前筛查为MA阳性的实际尿液样本,结果表明,通过不对称L-TPC-ChD方法和普通五氟丙酰化(PFPA-ChD)方法分别获得的D-和L-MA的两个浓度总和之间,以及由此获得的D-和L-AP的两个浓度总和之间,大多存在可接受的偏差,从而验证了所提出的分析方法作为一种有前景的法医协议,可用于详细分析尿液中的对映体苯丙胺。